The vaccine, called galinpepimut-S or GPS, was tested in patients with acute myeloid leukaemia, a fast-growing cancer of the blood and bone marrow
Sellas’ cancer vaccine extends survival in blood cancer trial, company says
Published ·

Keep reading
Related stories






